IMM 6.33% 42.0¢ immutep limited

My previous reply was to Ymav. FYI. Missed Andrew's...

  1. 701 Posts.
    My previous reply was to Ymav. FYI. Missed Andrew's post.

    Completely agree Andrew. Though I expect it possible in CVac's case, the FDA would approve based on PFS alone (fast track), as there is little risk to the patient.
    Avastin's approval for breast cancer was revoked primarily because the risks outweighed the benefit.
    This is where I went off-track with my incredulity in my above post - EMA vs FDA.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
42.0¢
Change
0.025(6.33%)
Mkt cap ! $598.3M
Open High Low Value Volume
39.5¢ 42.0¢ 39.5¢ $890.1K 2.163M

Buyers (Bids)

No. Vol. Price($)
3 127863 41.5¢
 

Sellers (Offers)

Price($) Vol. No.
42.5¢ 30850 2
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.